By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Hookipa Biotech 

Helmut-Qualtinger-Gasse 2

  Vienna  1030  Austria
Phone: 43-1-890-63-60 Fax: 43-1-890-63-60-399




Company News
Hookipa Biotech Announces Nature Communications Publication Showing Therat Turns Cold Tumors Hot 5/26/2017 8:55:34 AM
Hookipa Biotech Presents Positive Data From Phase I First-In-Human Trial Of Vaccine Against Cytomegalovirus 5/4/2017 9:37:54 AM
Reinhard Kandera Appointed Chief Financial Officer Of Hookipa Biotech 4/19/2017 8:06:03 AM
Dr Igor Matushansky Appointed Global Head, Research And Development Of Hookipa Biotech 3/6/2017 8:33:54 AM
Hookipa Biotech Announces Publication In Clinical And Vaccine Immunology Highlighting Vaxwave As An Effective Viral Vector For Vaccination Against Congenital Cytomegalovirus Infections 1/9/2017 10:19:54 AM
Hookipa Biotech Secures EUR 4.16 Million Additional Grant Support From The Austrian Research Promotion Agency (FFG) To Develop Arenavirus Vector-Based Cancer Immunotherapies 10/17/2016 10:45:02 AM
Dr. Torsten Mummenbrauer Appointed SVP Business Development & Licensing Of Hookipa Biotech 10/11/2016 10:11:49 AM
Hookipa Biotech Initiates First-in-Human Study Of Cytomegalovirus Vaccine 7/20/2016 9:47:53 AM
Jörn Aldag Appointed CEO Of Hookipa Biotech 6/16/2016 10:42:42 AM
Hookipa Biotech Wins Best Financing Deal Award In The Vaccine Industry Excellence (ViE) Awards 2014 3/31/2014 9:26:57 AM